Market Research Reports - Ken Research Robotic Assisted Surgical Devices (Rasd) Market | Page 2

Of the 3,919 da Vinci systems installed worldwide, 2,563 of them were installed in the US alone.
Europe, Asia-Pacific and Rest of the World (ROW) comprised for ~ %, ~ % and ~ % market share
as of 2017, respectively.
Snapshot on Us Robotic Surgery Market
The US accounted for more than ~% of the overall robotic surgery market in 2017, in terms of
revenue. Hence, the US robotic surgery market stood at over USD ~ billion in 2017. High
healthcare standards, financial capability of hospitals to invest in these systems, strategic
collaboration with insurance players, rising patient acceptance owing to superior post-operative
outcomes, and general awareness about computer-assisted surgeries have led to high adoption
of robot-assisted surgeries in the US.
The US is at the forefront of medical research and is more often the first country to adopt new,
innovative surgical robots for a variety of indications. Although robot-assisted surgeries are
expensive, insurers pay no more for surgeries that utilize robotic systems than for other types
of minimally-invasive procedures, such as laparoscopy. Higher treatment cost with surgical
robots has resulted in slower adoption of robotic surgeries amongst the citizens of the US.
Major Companies:
A vast majority of the companies developing and marketing surgical robots are based out of the
US. This includes the market leader Intuitive Surgical, which generated about ~% of its entire
annual revenues from the US itself in 2016. Several other major players in this sector such as
Accuray, Stryker, Zimmer Biomet, OMNIlife Science, Think Surgical, Restoration Robotics,
Medrobotics, TransEnterix and Auris Surgical are based in the US. Even those companies which
are not based out of the US, sale of robotic systems in the US contributed for a fair portion of
their overall annual revenues.
In terms of product development, US based medical device companies clearly dominated over
others in developing surgical robots indicated for radio surgery, hair transplant and soft tissue
surgeries involved in urology, gynecology, cardiothoracic and general surgical procedures.
Market Potential:
At present, the US is currently experiencing a severe shortage of general surgeons. The number
of total active physicians in all specialties rose less than 2% annually to 860,939 in 2015 from
799,501 in 2010, according to the AAMC’s (Association of American Medical Colleges) 2016
Physician Specialty Data Report. The US will face a shortage of between 61,700 and 94,700
doctors by 2025, according to AAMC.